Class of 2026
For celebrated research centered on epigenetic gene silencing in prostate cancer, including the discovery of glutathione S-transferase P1 gene (GSTP1) promoter CpG island hypermethylation, the most common somatic alteration in prostate cancer, thereby establishing a molecular rationale for biomarker development that has led to transformative diagnostic advances in prostate cancer detection, stratification, prevention, and treatment.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]